How to effectively manage recurrent myocardial infarctions?

Question

Hi doctor,

I have been struggling with recurring myocardial infarctions for years and have explored nearly every available treatment option. Despite undergoing medications, surgical interventions, and even experimental therapies, nothing has provided lasting relief. Most recently, I underwent stem cell therapy in the hope of regenerating my heart tissue, but unfortunately, it failed to improve my condition.

I continue to experience debilitating chest pain, persistent fatigue, and shortness of breath, all of which severely impact my quality of life. It feels like I have exhausted both standard and advanced treatment avenues, leaving me increasingly desperate for a solution.

Are there any emerging or experimental therapies—such as gene therapy, novel pharmacological agents, or advanced regenerative medicine—that could offer me a new chance at recovery?

I am open to participating in clinical trials or exploring any cutting-edge treatments that might help stabilize my heart function. Any guidance on alternative steps I can take would be greatly appreciated, as I am unsure how much longer I can endure these relentless symptoms.

Please help me.

Thanks.

Answer 1

Hi,

Welcome to icliniq.com.

I can understand your concern.

There have been significant advances in adjunctive pharmacotherapy, procedural techniques, and stent technology in the treatment of patients with myocardial infarctions. The routine use of antiplatelet agents such as Clopidogrel, Prasugrel, or Ticagrelor, in addition to Aspirin, reduces patient morbidity and mortality.

Gene therapy, specifically the application of various miRNAs, antioxidant gene activators, and molecules, whose target is oxidative stress, is a very promising approach to eliminating reactive oxygen species (ROS) after MI and hypoxia or reoxygenation conditions, and to improve cardiac function.

At present, small-molecule drugs that may be used to treat myocardial infarction include prostaglandins, prostaglandin E2, prostaglandin I2, pyrvinium pamoate, and dipeptidyl peptidase 4.

Feel free to follow up with any further questions or concerns.

Thank you.